Specialty Enzymes: Market Research Report
This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 44 companies including many key and niche players such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories Limited, Danisco A/S, Genencor International, Inc., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability And Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions And Scope Of Study
Specialty Medical Enzymes
Polymerases
Nucleases
Other Specialty Enzymes
Pharmaceuticals/Diagnostic
Research/Biotechnology
2.GLOBAL MARKET OVERVIEW
Current and Future Analysis
Recession Derails the Market Momentum
Competitive Scenario
Table 1: Leading Players in the Global Enzyme Market (2009): Percentage Breakdown of Value Sales for Novozymes, Danisco, Genzyme, Roche, Allergan, DSM and Others (includes corresponding Graph/Chart)
3.ENZYMES - A REVIEW
Definition
Introduction
Advantages of Enzymes Compared to Chemical Catalysts
A Brief History
4.SPECIALTY ENZYMES: AN OVERVIEW
Analysis of Product Segments
Specialty Medical Enzymes
Polymerases
Nucleases
Other Specialty Enzymes
5.ANALYSIS OF THE END-USE MARKETS
Pharmaceuticals & Diagnostics
Research/Biotechnology
Other End Use Markets
6.TECHNOLOGY TRENDS
Protein Engineering Technology
Specialty Enzymes in Industrial Uses
Enzyme Technology in Pig Industry
7.PRODUCT INTRODUCTIONS/INNOVATIONS
Verenium Launches Xylathin
Novagen Introduces Novagen® KOD XtremeTM Hot Start DNA Polymerase Kit
Verenium Launches New Veretase High-Performance Enzyme
8.PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST – A PERSPECTIVE BUILDER
MARDI Develops Taq DNA Polymerase
Stratagene Corporation Commercializes DNA Polymerases
Takara Bio Launches PrimeSTAR HS DNA Polymerase
9.RECENT INDUSTRY ACTIVITY
Thermo Fisher Scientific Acquires Finnzymes
Verenium and Add Food Service Enter into an Agreement
Verenium and Syngenta End Collaborative Research Program
Verenium Collaborates with Alfa Laval for Purifine PLC Enzyme
Verenium and Bunge Enter into an Agreement for Enzyme Process Development
Inverness Medical Innovations Acquires BBI Holdings Plc
Helix Biopharma Enters into a Contract with KBI Biopharma
Verenium Enters into Agreement with Bunge Oils
10.CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER
BBI Holdings Acquires Theratase Plc
Danisco to Acquire Stake in South African Firm
Affymetrix to Buy USB Corporation
Diversa Merges with Celunol to Form Verenium Corporation
Diversa Collaborates with BASF
Codexis Expands Collaboration with Royal Dutch Shell to Develop Super Enzymes
Diversa Enters into a Deal with Syngenta to Develop Enzymes
Genencor Begins Operation at New China Site and Introduces a New Detergent Enzyme
Verenium Receives $4.6 million For Enzyme Development
Biocon Divests its Enzymes Business to Novozymes
Solexa Signs Agreement with New England Biolabs
Danisco Takes Over Genencor
IBEX Technologies Inks Agreement with Cape Cod and Prozyme
11.FOCUS ON SELECT GLOBAL PLAYERS
Advanced Enzymes Technologies Limited (India)
Amano Enzyme, Inc. (Japan)
Aureozyme, Inc. (US)
Biocon Ltd. (India)
Biozyme Laboratories Limited (UK)
Danisco A/S (Denmark)
Genencor International, Inc. (US)
Kinetic Biosystems, Inc. (US)
Maxygen, Inc. (US)
Codexis Inc. (US)
Novozymes A/S (Denmark)
Seravac Biotech (Pty) Ltd. (South Africa)
Specialty Enzymes & Biotechnologies Co. (US)
Verenium Corporation (US)
12.GLOBAL MARKET PERSPECTIVE
Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 3: World Historic Review for Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 4: World 11-Year Perspective for Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 5: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 6: World Historic Review for Specialty Medical Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 7: World 11-Year Perspective for Specialty Medical Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 8: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Polymerases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 10: World 11-Year Perspective for Polymerases by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 11: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 12: World Historic Review for Nucleases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 13: World 11-Year Perspective for Nucleases by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 14: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 15: World Historic Review for Other Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 16: World 11-Year Perspective for Other Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 17: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 18: World Historic Review for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 19: World 11-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 20: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 21: World Historic Review for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 22: World 11-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 23: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 24: World Historic Review for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 25: World 11-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
13.THE UNITED STATES
A. Market Analysis
Current and Future Analysis
Competitive Scenario
Table 26: Leading Players in the US Enzyme Market (2008): Percentage Breakdown of Value Sales for Novozymes, Danisco, Allergan, Genzyme, Genentech, and Others (includes corresponding Graph/Chart)
Market Dynamics
Specialty Enzymes Market is Projected to Rise
Specialty Enzymes Form the Leading Enzymes Segment
Pharmaceuticals and Diagnostics Continue to be the Largest Market
Specialty Medical Enzymes in a Myriad of Novel Applications
Market for Enzymes in Biotechnology
B. Market Analytics
Table 27: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 28: US Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 29: US 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 30: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 31: US Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 32: US 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
14.CANADA
Market Analysis
Table 33: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart)
Table 34: Canadian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 35: Canadian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 36: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 37: Canadian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 38: Canadian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
15.JAPAN
Market Analysis
Table 39: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 40: Japanese Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 41: Japanese 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 42: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 43: Japanese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 44: Japanese 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16.EUROPE
Market Analysis
Table 45: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 46: European Historic Review for Specialty Enzymes by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 47: European 11-Year Perspective for Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 48: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 49: European Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 50: European 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 51: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 52: European Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 53: European 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16A.FRANCE
Market Analysis
Table 54: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 55: French Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 56: French 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 57: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 58: French Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 59: French 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16B.GERMANY
Market Analysis
Table 60: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 61: German Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 62: German 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 63: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 64: German Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 65: German 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16C.ITALY
Market Analysis
Table 66: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 67: Italian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 68: Italian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 69: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 70: Italian Historic Review for Specialty Enzymes by End-Use Segment – Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 71: Italian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16D.THE UNITED KINGDOM
Market Analysis
Table 72: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 73: UK Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 74: UK 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 75: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 76: UK Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 77: UK 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015 (includes corresponding Graph/Chart)
16E.SPAIN
Market Analysis
Table 78: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 79: Spanish Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 80: Spanish 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015(includes corresponding Graph/Chart)
Table 81: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart)
Table 82: Spanish Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 83: Spanish 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16F.RUSSIA
Market Analysis
Table 84: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 85: Russian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 86: Russian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 87: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 88: Russian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 89: Russian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16G.REST OF EUROPE
Market Analysis
Table 90: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 91: Rest of Europe Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 92: Rest of Europe 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 93: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 94: Rest of Europe Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 95: Rest of Europe 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
17.ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
Enzyme Market in China
Enzyme Demand by End-Use
Table 96: Chinese Enzyme Market (2009): Percentage Breakdown of Dollar Demand by End-Use Market – Industrial (Food & Beverage, Cleaning Products, Animal Feed, Ethanol Production, and Other Industrial) and Specialty (includes corresponding Graph/Chart)
Enzyme Demand by Enzyme Type
Table 97: Chinese Enzyme Market (2009): Percentage Breakdown of Dollar Demand by Enzyme Type – Carbohydrases (Amylases and Other Carbohydrases), Proteases, Lipases, Polymerases & Nucleases, and Other Enzymes (includes corresponding Graph/Chart)
B. Market Analytics
Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 99: Asia-Pacific Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 100: Asia-Pacific 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 102: Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 103: Asia-Pacific 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
18.THE MIDDLE EAST
Market Analysis
Table 104: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 105: Middle East Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 106: Middle East 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 107: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 108: Middle East Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 109: Middle East 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
19.LATIN AMERICA
Market Analysis
Table 110: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 111: Latin American Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 112: Latin American 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 113: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 114: Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 115: Latin American 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Competition
Total Companies Profiled: 44 (including Divisions/Subsidiaries - 46)
Region/CountryPlayers
The United States25
Canada
Japan
Europe
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Africa
Please read Global Industry Analysts, Inc., - Sales Policy below before placing an order:
All Publications from Global Industry Analysts, Inc., (GIA) are protected per protocols of the Universal Copyrights Convention and the United States Copyrights Office. It is GIA’s policy that once purchased, these publications may not be returned for any reason. GIA makes all reasonable attempts to report current and accurate information in its publications.
GIA will not be responsible for any type of damages (financial or other) incurred by the client (company or individual) in the usage of GIA’s publications or services. The client agrees that in case a legal resolution becomes necessary, the venue shall be the city of San Francisco, California, USA. Under any circumstances, GIA’s liability shall be limited to the exact price of the product or service paid to GIA by the client.
This publication is sold as a single-user single-site license. Electronic versions operate like normal PDF files once installed and permit unlimited print and cut & paste. Digital controls and watermarks are set on electronic copies and are protected against copying. Extra licenses can be purchased for the same location at 10% of the list price.